GBT
LLY icon

Grove Bank & Trust’s Eli Lilly LLY Stock Holding History

Grove Bank & Trust’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.08M Sell
7,571
-48
-0.6% -$49K 0.9% 30
2026
Q1 		$7.01M Sell
7,619
-289
-4% -$293K 0.79% 35
2025
Q4 		$8.5M Sell
7,908
-1,574
-17% -$1.51M 0.96% 30
2025
Q3 		$7.23M Sell
9,482
-326
-3% -$243K 0.85% 35
2025
Q2 		$7.65M Sell
9,808
-139
-1% -$108K 0.95% 27
2025
Q1 		$8.22M Buy
9,947
+1,899
+24% +$1.58M 1.1% 18
2024
Q4 		$6.21M Buy
8,048
+2,019
+33% +$1.67M 0.86% 28
2024
Q3 		$5.34M Buy
6,029
+125
+2% +$112K 0.79% 27
2024
Q2 		$5.35M Buy
5,904
+100
+2% +$80K 0.86% 25
2024
Q1 		$4.52M Buy
5,804
+72
+1% +$51.2K 0.76% 28
2023
Q4 		$3.34M Buy
5,732
+96
+2% +$56K 0.61% 36
2023
Q3 		$3.03M Buy
5,636
+511
+10% +$263K 0.62% 35
2023
Q2 		$2.4M Sell
5,125
-21
-0.4% -$8.81K 0.49% 41
2023
Q1 		$1.77M Sell
5,146
-1,022
-17% -$345K 0.37% 56
2022
Q4 		$2.26M Sell
6,168
-1,131
-15% -$401K 0.5% 42
2022
Q3 		$2.36M Buy
7,299
+100
+1% +$31.7K 0.58% 37
2022
Q2 		$2.33M Buy
7,199
+49
+0.7% +$14.7K 0.56% 43
2022
Q1 		$2.05M Buy
7,150
+209
+3% +$53.8K 0.4% 58
2021
Q4 		$1.92M Buy
6,941
+184
+3% +$46.6K 0.37% 60
2021
Q3 		$1.56M Buy
6,757
+133
+2% +$32.8K 0.33% 68
2021
Q2 		$1.52M Sell
6,624
-14
-0.2% -$2.81K 0.33% 70
2021
Q1 		$1.24M Sell
6,638
-13
-0.2% -$2.54K 0.29% 78
2020
Q4 		$1.12M Buy
6,651
+442
+7% +$66K 0.29% 80
2020
Q3 		$919K Sell
6,209
-79
-1% -$12.2K 0.28% 85
2020
Q2 		$1.03M Buy
6,288
+181
+3% +$27.8K 0.34% 73
2020
Q1 		$847K Sell
6,107
-250
-4% -$34.4K 0.33% 80
2019
Q4 		$835K Sell
6,357
-90
-1% -$10.4K 0.25% 95
2019
Q3 		$721K Buy
6,447
+712
+12% +$79.3K 0.23% 97
2019
Q2 		$635K Sell
5,735
-16
-0.3% -$1.88K 0.23% 95
2019
Q1 		$747K Buy
5,751
+39
+0.7% +$4.74K 0.29% 85
2018
Q4 		$661K Buy
5,712
+267
+5% +$29.8K 0.31% 81
2018
Q3 		$584K Sell
5,445
-14
-0.3% -$1.4K 0.24% 97
2018
Q2 		$466K Sell
5,459
-310
-5% -$25.5K 0.2% 111
2018
Q1 		$446K Sell
5,769
-160
-3% -$12.9K 0.2% 117
2017
Q4 		$501K Sell
5,929
-356
-6% -$30.3K 0.22% 104
2017
Q3 		$538K Sell
6,285
-1,560
-20% -$128K 0.26% 94
2017
Q2 		$646K Buy
7,845
+2,850
+57% +$233K 0.41% 61
2017
Q1 		$420K Buy
4,995
+1,760
+54% +$141K 0.34% 59
2016
Q4 		$238K Buy
3,235
+1,735
+116% +$129K 0.18% 96
2016
Q3 		$120K Sell
1,500
-50
-3% -$4K 0.1% 115
2016
Q2 		$122K Buy
1,550
+50
+3% +$3.76K 0.11% 111
2016
Q1 		$108K Hold
1,500
– – 0.1% 116
2015
Q4 		$126K Buy
+1,500
New +$124K 0.11% 116

Other funds holding LLY

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
SC
Sapient Capital Indianapolis, Indiana $7.64B AUM 51.51% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
ONB
Old National Bancorp Evansville, Indiana $5.02B AUM 25.65% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
GIM
Goelzer Investment Management Carmel, Indiana $2.29B AUM 39.12% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
WAM
Weatherly Asset Management Del Mar, California $1.4B AUM 36.32% 1-Year Est. Return
CRM
Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return

Grove Bank & Trust's LLY Position: Q2 2026 in Review

Grove Bank & Trust reduced its Eli Lilly (LLY) stake by 0.63% in Q2 2026, selling an estimated $49K and leaving 7,571 shares worth $9.08M. The position accounts for 0.9% of the portfolio, ranked #30.

Grove Bank & Trust first reported a position in LLY in Q4 2015 and has held it in 43 quarters since. 1,102 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Grove Bank & Trust held 7,571 shares of Eli Lilly worth $9.08M as of Q2 2026.
  • Grove Bank & Trust sold 48 Eli Lilly shares in Q2 2026, an estimated $49K.
  • Eli Lilly made up 0.9% of Grove Bank & Trust's portfolio in Q2 2026, its #30 holding.
  • Grove Bank & Trust first reported a position in Eli Lilly in Q4 2015 and has held it in 43 quarters since.
  • 1,102 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Grove Bank & Trust's 13F filing for Q2 2026, filed 7 Jul 2026.